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Abstract
Background: The first report on the transferable, plasmid-mediated quinolone-resistance determinant qnrA1 was in
1998. Since then, qnr alleles have been discovered worldwide in clinical strains of Gram-negative bacilli. Qnr
proteins confer quinolone resistance, and belong to the pentapeptide repeat protein (PRP) family. Several PRP
crystal structures have been solved, but little is known about the functional significance of their structural
arrangement.
Results: We conducted random and site-directed mutagenesis on qnrA1 and on qnrC, a newly identified
quinolone-resistance gene from Proteus mirabilis. Many of the Qnr mutants lost their quinolone resistance function.
The highly conserved hydrophobic Leu or Phe residues at the center of the pentapeptide repeats are known as
i sites, and loss-of-function mutations included replacement of the i site hydrophobic residues with charged
residues, replacing the i
-2 site, N-terminal to the i residues, with bulky side-chain residues, introducing Pro into the
b-helix coil, deletion of the N- and C-termini, and excision of a central coil. Molecular dynamics simulations and
homology modeling demonstrated that QnrC overall adopts a stable b-helix fold and shares more similarities with
MfpA than with other PRP structures. Based on homology modeling and molecular dynamics simulation, the
dysfunctional point mutations introduced structural deformations into the quadrilateral b-helix structure of PRPs. Of
the pentapeptides of QnrC, two-thirds adopted a type II b-turn, while the rest adopted type IV turns. A gap exists
between coil 2 and coil 3 in the QnrC model structure, introducing a structural flexibility that is similar to that seen
in MfpA.
Conclusion: The hydrophobic core and the b-helix backbone conformation are important for maintaining the
quinolone resistance property of Qnr proteins. QnrC may share structural similarity with MfpA.
Background
Quinolones constitute an important group of antimicro-
bials active against Gram-negative and Gram-positive
bacteria. Because of wide clinical use, clinical isolates
resistant to fluoroquinolone are emerging and spreading
rapidly. In China, more than 60% of Escherichia coli
strains isolated from hospital-acquired infections are
resistant to fluoroquinolone, and 50.6% of E. coli strains
from community-acquired infections are ciprofloxacin-
resistant [1]. The resistance mechanism of these drugs
was considered to be chromosomally encoded until the
discovery of the plasmid-mediated qnrA gene in 1998 [2].
Thereafter, additional qnr genes (qnrA, qnrB, qnrS, qnrD)
on resistance plasmids were identified worldwide, in var-
ious bacterial pathogens. The chromosomes of Vibriona-
ceae, Stenotrophomonas maltophilia, and Gram-positive
genera were found to contain qnr-like genes [3-5]. More
recently, our research group reported a new qnr gene,
qnrC, found in a clinical strain of Proteus mirabilis [6].
The Qnr proteins belong to the pentapeptide repeat
protein (PRP) family. The QnrA protein competes with
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QnrA may provide quinolone resistance by acting as a
DNA mimic. PRP proteins, which contain characteristic
tandem pentapeptide repeats [A/C/S/T/V] [D/N] [L/F]
[S/T/R] [G/R] [[3,7,9,10], Fig. 1], are most abundant in
cyanobacteria, and are widely distributed in prokaryotes
[9]. The highly conserved hydrophobic residues (Leu or
Phe) at the center of the pentapeptide repeats are
usually designated as site i, with the residues N-terminal
to i as the i
-2 and i
-1 sites, and the residues C-terminal
to i as the i
+1 and i
+2 s i t e s[ F i g .1 ] .T od a t e ,o n l ys i x
PRP family crystal structures have been determined
[11-16]. These structures showed that all PRPs adopt a
right-handed quadrilateral b-helix (RHQBH) fold. Every
four pentapeptide repeats form a nearly square repeating
unit, termed a coil. The coils are stacked atop one
another to facilitate hydrogen bonding between neigh-
boring coils. The two predominant main chain confor-
mations encoded by the pentapeptide repeat sequence
differ only in the orientation of a single peptide bond
between residue i and i
+1. In the type II turns composed
of the i, i
+1, i
+2 and i
-2 residues, the main chain j-ψ
angles of residues in i and i
+1 are (-120, 20) and (-60,
120) respectively, while in the type IV turns the j-ψ
angles of residue i and i
+1 are (-120, 120) and (-120,
120). The residue side chains are also regularly posi-
tioned. The residues at site i and i
-2 are packed inside
the b-helix forming a hydrophobic core, while the resi-
dues at sites i
-1, i
+1 and i
+2 are exposed to solvent [9].
Among the resolved structures of PRPs, MfpA [[11],
2bm4] and EfsQnr [[15], 2w7z] present a unique rod-
shaped dimer form, in which the two monomers associ-
ate through their C-terminal helices. This dimer assem-
bly was proposed to be a DNA mimic, and shown to be
capable of binding to DNA gyrase in vitro [11]. MfpA is
a good model for Qnr proteins, as they all possess a
characteristic PRP sequence and share the same target
protein [7,11,17]. Although the sequence and structural
characteristic of PRPs have been determined, the rela-
tionship between their structure and function remains
elusive.
In this study, mutagenesis was carried out on different
parts of QnrC and QnrA1, to explore the functional
importance of the targeted residues. Many mutants were
found to lose their ability to confer ciprofloxacin resis-
tance. Combined with computational simulations and
homology modeling, we found that the hydrophobic
core and the b-helix backbone conformation are impor-
tant for the quinolone resistance function of QnrC and
QnrA1.
Results
1. Quinolone resistance phenotypes of QnrC and QnrA1
mutants
E. coli TOP10 cells harboring wild type qnrC in plasmid
pHS12, or wild type qnrA1 in plasmid pMG252-1 both
had a minimal inhibitory concentration (MIC) for cipro-
floxacin of 0.125 μgm l
-1 (Table 1). Mutants of these
genes were classified into four groups.
1) Mutations in i or i
-2
In all known PRP crystal structures, the residues at i
and i
-2 have side chains that pack inward, forming a
hydrophobic core of RHQBH. When the hydrophobic
residues at i were substituted with residues with polar
Figure 1 The pentapeptide repeats of QnrC, QnrA1 and MfpA.
The characteristic pentapeptide repetitions are [A/C/S/T/V] [D/N] [L/
F] [S/T/R] [G/R], highlighted in red. The conserved hydrophobic
residue at the center of pentapeptide alignments is designated as i,
while the residues N-terminal to the i residue are designated as i
-1
and i
-2 and the residues C-terminal to the i residue as i
+1 and i
+2.
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Page 2 of 11or charged side chains, the ciprofloxacin MICs
decreased. For example, mutation F13 S had an MIC of
0.003 μgm l
-1, and L38R had an MIC of 0.008 μgm l
-1,
indicating loss of quinolone resistance. The control,
which was substitution of i with neutral or hydrophobic
side chain residues such as L38A or L38F, did not
reduce MICs (Table 1). At i
-2, substitution of Tyr, which
has a bulky side chain, for Cys or Ala, as in the C72Y
and A97Y mutants, completely destroyed activity. These
data indicated that the i region excludes polarized and
charged residues, and i
-2 tends to be sensitive to the
presence of bulky side chains.
2) Introduction of proline
All random mutants lost activity when Pro was intro-
duced into the pentapeptide repeat sequence in the i, i
-1
or i
+2 regions, as seen in mutations L38P, S116P, and
S153P (Table 1).
3) Cys to Ser mutations
Cys residues are abundant in Qnr proteins, relative to
other PRPs. We introduced single point mutations of
Cys to Ser to perform a complete search of potential
disulfide bonds in PRPs [13]. The mutations all involved
Cys in QnrA1, in i
-2 (residues 26, 31, 36, 46, 57, 72, 92,
122, 137), i
-1 (residue 133), i (residue 84), i
+1 (residue
Table 1 Ciprofloxacin susceptibility of QnrC and QnrA1 mutants
Groups/clusters Mutagenesis and codon alteration
a Position of
mutation
Qnr
protein
MIC (μg
ml
-1)
pHSG398 - - 0.002
Control pHS12 wild type QnrC 0.125
pMG252-1 wild type QnrA1 0.125
L38R(TTA®AGA) i QnrC 0.003
L38A(TTA®GCA) i QnrC 0.125
Hydrophobic interior of b-helix L38F(CTG®TTC) i QnrA1 0.125
F13S(TTC®TCC)
c i QnrA1 0.008
C72Y(TGC®TAC) or A97Y(GCT®TAT) i
-2 QnrC 0.003
S116P (TCT®CCT)
c i
+2 QnrC 0.002
Constraint effect of Pro to the
backbone
S153P(TCT®CCT)
c i
-1 QnrC 0.003
L38P(CTG®CCG)
c i QnrA1 0.004
C84S(TGT®TCT) i QnrC 0.094
C84S(TGC®AGC) i QnrA1 0.064
Cys to Ser mutation C31 S or C36 S or C57 S or C177 S (TGT®AGT);
C26 S or C46 S or C72 S or C92 S or C122 S or C137S(TGC®AGC)
i
-2 QnrA1 0.125
C133S(TGC®AGC)or C168S(TGT®AGT) i
-1 QnrA1 0.125
C115S(TGC®AGC)or C200S(TGT®AGT) i
+1 QnrA1 0.125
Δ11-20 N-terminus QnrC 0.003
Δ2-21 N-terminus QnrA1 0.002
Δ2-10 N-terminus QnrA1 0.003
Δ49-55 G56 region QnrC 0.003
Fragment truncation b Δ41-56, Δ51-56 G56 region QnrA1 0.003
Δ77-96, Δ137-156 b-helix backbone QnrC 0.003
Δ216-218 C-terminus QnrC 0.064
Δ187-218 C-terminus QnrA1 0.003
Δ207-218 C-terminus QnrA1 0.004
D188V (GAC®GTC)
c i
+1 QnrA1 0.003
Others M44T(ATG®ACG) i
+1 QnrC 0.125
I216T (ATT®ACT)
c i
+2 QnrC 0.125
E50A(GAA®GCC) or E50G (GAA®GGC) or E55A (GAA®GCT) or
E55G(GAA®GGA)
i
+2 QnrA1 0.125
a nucleotide substitution is in parentheses.
b Δ2-21 indicates deletion of amino acids 2-21.
c mutations were obtained by random mutagenesis and confirmed by site-directed mutagenesis.
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Page 3 of 11115), and in some non-pentapeptide repeat residues
(residues 168, 177, 200). Most of these mutations
showed little variation in MIC values, regardless of
whether the mutated side chains were originally inward-
facing (position i
-2)o ro u t w a r d - f a c i n g( p o s i t i o ni
-1 and
i
+1). Only the C84 S mutants showed an obvious
decrease in ciprofloxacin MIC, from 0.125 μgm l
-1 to
0.064 for QnrA1. When we introduced a C84 S muta-
tion into QnrC, the MIC decreased to 0.094 μgm l
-1
(Table 1). Therefore, replacement of the sulfhydryl
group with a hydroxyl group was tolerated, suggesting
that either no disulfide bond was formed at the site, or
a disulfide bond was formed, but was not essential for
activity.
4) Fragment truncation of Qnr proteins
The N-, and C-terminal residues, and the coils in the
middle of the b-helix were truncated to determine their
potential functional importance. Ciprofloxacin MIC
values showed that increased susceptibility resulted from
removal of residues 2-21, 2-10, and 11-20 at or near the
N-terminus of the Qnr proteins; residues 187-218, 207-
218 and 216-218 at the C-terminus; residues 41-56, 49-
55, and 51-56 around the G56 region; or removal of
residues 77-96 and 137-156, corresponding to the intact
coils of the b-helix (Table 1).
5) Other mutations
The D188V mutation proximal to the C-terminus of
QnrA1 conferred increased susceptibility to ciprofloxa-
cin. The mutations M44T, I216T, E50G, E50A, E55G
and E55A did not affect quinolone resistance activity
(Table 1).
2. Molecular dynamics simulations
1) Stability of wild-type MfpA structure
A 10-ns molecular dynamics (MD) trajectory revealed
that the structure of the wild-type MfpA dimer has high
stability. The typical right-handed quadrilateral b-helix
(RHQBH) backbone of each monomer varied little, with
the Ca root-mean-square deviation (RMSD) value fluctu-
ating around 0.8 Å throughout the simulation. The
hydrophobic core inside the b-helix remained stable, and
the hydrogen networks between coils were also well pre-
served. In spite of the stable conformation, the individual
monomers underwent obvious relative bending motions
around the hinge at the dimer interface. However, this
motion did not disrupt the connections between the
monomers, which included the hydrogen bond network
between G161, A162, R163 and V164 at the last b-helix
coil of one monomer, and G177 and C179 at the C-ter-
minus of the opposite monomer. The van der Waals
interactions between the hydrophobic side chains of the
C-terminal a-helices also contributed to the connection.
Overall, the C-terminus of each monomer seemed to be
essential for MfpA dimer assembly.
2) Mutations at site i
The high conservation at the i site implied its importance
to the structure and function of PRPs. The Phe or Leu
residues form a hydrophobic core within the protein, so
we examined the structural variations of two Leu to Asp
mutants to see the effect of a strong polar side chain at the
i site. In both L39 D and L104 D mutants, the acidic side
chains showed a strong tendency to escape from the
hydrophobic core, and the nearby backbones also distorted
distinctly from the typical RHQBH structure. The L104 D
mutant exhibited more striking variation. The D104 side
chain flipped over from the initial orientation pointing
toward the hydrophobic core to face the solvent environ-
ment (Fig. 2d). This reorientation occurred just after the
beginning of the simulation. In contrast, the wild-type
L104 alkyl chain remained oriented toward the interior
space throughout the 10-ns trajectory (Fig. 2b). The reor-
ientation of the side chains distorted the local backbone in
the vicinity of D104 (Fig. 2d). This enlarged the coil-coil
distance, creating a gap between them. The local hydrogen
bond networks between the coils were also disrupted.
These structural changes indicated that the hydrophobic
core could not accommodate charged residues at the i site,
verifying the importance of the conserved hydrophobic
residues to PRP structural stability. This is consistent with
the observed dysfunction of the F13 S and L38R mutants.
3) Constraining effect of proline on the backbone
Pro mutations caused dysfunction, as observed with the
L38P, S116P and S153P mutants. This might be attribu-
ted to the conformational restraints of proline residues
on the protein backbone. We introduced Pro at L114
(position i)i nM f p Aa n df o u n dt h a tt h ep r o t e i nw a s
substantially perturbed in two ways. First, we noted an
increased distance between P114 and T134, a residue
within i of the neighboring coil (Fig. 3). This could be
largely attributed to the missing backbone amide in
P114, leading to the disruption of the original backbone
hydrogen bond between the L114 amide and the K133
carbonyl in the wild type protein. Thus, the intercoil
interaction was weakened and the fluctuation amplitude
of coils increased. The second remarkable change was
around T117 (position i
-2). In the wild type protein, the
T117 hydroxyl group is buried in the b-turn region to
form hydrogen bonds with the backbone of L104 and
V105. The L114P mutation changed the T117 side
chain orientation. The hydroxyl group of T117 pointed
towards N97, and interacted with its carbonyl. To
accommodate the side chain rearrangements, the back-
bone distorted, resulting in the increased distance
between T117 and its preceding coil (Fig. 3).
3. Homology modeling of QnrC protein
Several crystal structures of PRPs have been reported,
but no structure template had a sequence identity with
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Page 4 of 11QnrC higher than 30%. However, structural studies so
far have revealed that the pentapeptide repeat sequences
in PRPs adopt a right-handed quadrilateral b-helix fold,
despite the sequence diversity (Fig. 4). Based on these
observations, we inferred that the pentapeptide repeat
sequences in QnrC fold into a similar structure. How-
ever, the pentapeptide repeats make conventional
sequence alignment difficult. Nonetheless, the periodic
structural feature of the quadrilateral b-helix ensures
that the general location and conformation of the side
chains and intercoil interactions are conserved among
different alignments. If we confine the model building
within the regular pentapeptide repeat sequence, the
model structure may have higher reliability than
expected from the sequence similarity between the tar-
get and template. We excluded the C-terminal part of
QnrC (166-221) from model building because of the
lack of a regular pentapeptide repeat. As a template, we
used the crystal structure of the pentapeptide repeat
protein Np275/276 (PDBID: 2J8K), from which the N-
and C-terminal regions (1-14, 168-175), which deviate
from the regular quadrilateral b-helix structure, were
removed. After truncation, the template was 11 amino
acids shorter than QnrC. Therefore, a fragment of the
previous coil (from H148 to T158) was duplicated and
added after L167. Within QnrC (1-165) however, the
regular pentapeptide repeat is disrupted by an abnormal
six-residue motif (
51SNDFEG
56), which brings uncer-
tainty into the model building. Therefore, we simply
aligned the six-residue motif in one quadrilateral face in
the initial homology model building, and subjected this
to optimization using MD simulation.
Figure 2 Structure perturbation induced by L104 D mutation in MfpA. (a) Part of the structure of wild type MfpA at the end of 10-ns MD
simulation. The side chain of L104 (magenta) is packed in the hydrophobic core of the b helix; (b) bottom view of (a); (c) Part of the structure
of MfpA L104 D mutant at the end of 10-ns MD simulation. The side chain of D104 (orange) is exposed to solvent, inducing local structure
deformation; (d) bottom view of (c).
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165) optimized by 10-ns MD simulation retained the
orderly b-helix fold overall (Fig. 5a). The highly con-
served Phe and Leu residues in the i site retained van
der Waals contact with each other and with the neigh-
boring coils, that formed the hydrophobic core. The
coils stacked atop one another and were stabilized by
hydrogen bond interactions. Nearly two-thirds of penta-
peptides adopted type II b-turns with the carbonyl of an
i residue hydrogen bonding to the amide of an i
-2 resi-
due in the following pentapeptide. The rest of the pen-
tapeptides adopted type IV b-turns, in which the main
chain atoms of both i and i
+1 residues participated in
intercoil hydrogen bonding. Some of the type IV turns
were located near the N-terminus (Fig. 5b and 5c), as
observed in MfpA [11]. We also noted that most turns
on face 3 were type IV, while the other faces were domi-
nated by type II turns. The distribution of the two types
of b-turns is proposed to be related to the sequence
identity of the residues at specific positions [9].
After optimization by MD simulation, the abnormal
six-residue motif (51 to 56) was seen to introduce struc-
tural deviations from the typical b-helix arrangement,
including a large separation between coil 3 and coil 2.
The hydrogen bonds between the backbone of the hexa-
peptide and its following coil were well preserved, while
the initial hydrogen bonds between the hexapeptide and
coil 2 disappeared because of the large intercoil distance.
(Fig. 6a). Along the MD simulation trajectory of QnrC,
the intercoil distance between coil 3 and coil 2 near the
gap underwent much larger fluctuations than the rest of
the protein (Fig. 6b), implying additional structural flex-
ibility in QnrC.
The C-terminal part of QnrC was not included in our
homology modeling because of the lack of a template
with high sequence homology. However, secondary
structure prediction showed an additional a-helix near
the very C-terminus (200~210 aa), implying a similar
structural arrangement of QnrC with MfpA at this
region. Taken together, the partial model structure of
QnrC based on homology modeling and MD simulation
suggested an overall structural arrangement and features
of QnrC that may be highly similar to MfpA. However,
we note uncertainties in this model structure, and analy-
sis awaits verification from future structural studies.
Discussion
The qnr gene and its variants carried by plasmids are
widely distributed in clinical isolates, and provide low-
level quinolone resistance. To date, more than 30 qnr
alleles have been identified, with seven QnrA alleles,
four QnrS alleles, twenty-four QnrB alleles, one QnrC
and one QnrD, and more than 50 amino acid alterations
described [[18], http://www.lahey.org/qnrStudies]. How-
ever, little is known about the potential influence of sin-
gle mutations on Qnr protein function. Random
mutagenesis was carried out by Cattoir et al., who found
no mutants of QnrA or QnrS with an elevated MIC for
quinolones. In contrast, MICs for quinolones for C115Y
mutations decreased 2.5-to-5-fold relative to wild type
strains [19]. Rodríguez-Martínez et al. found only one
mutant with increased quinolone resistance: QnrS1,
which contains D185Y with four folds for ciprofloxacin
[20]. Mutations at G56-, G56 D, C72Y, C92Y, G96 D, or
L159 D in QnrA1, QnrB1, or QnrS1 cause reduced
activity for ciprofloxacin [20]. In this study, no random
Figure 3 Structure perturbation induced by L114P mutation in MfpA. Top view (a) and side view (b) of the superimposed wild type (blue)
and L114P mutant (pink) structures after 10-ns MD simulation. Only part of the structure (residue 87 to 148) is shown. The side chain of T117 in
the L114P mutant is in green, with red balls for hydroxyl oxygen atom. The side chain of P114 residue is in yellow.
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have elevated resistance to ciprofloxacin. Synonymous
mutations occurred frequently, along with some non-
synonymous mutants with unchanged function. This is
consistent with the high diversity of Qnr variants in
clinical isolates. Many mutants have disabled ciprofloxa-
cin resistance activity caused by only a single amino
acid substitution for a conserved or unconserved resi-
due. Examples include substitution of the conserved
hydrophobic Leu or Phe residues with polar or positively
charged residues (L38R, F13S) in the i site, residues with
small side chains substituted with residues with bulky
side chains (C72Y, A97Y) in the i
-2 site, and charged
residues substituted for non-polar residues (D188V). In
addition, when a Pro occurred in the regular b-helix at
the i, i
-1,o ri
+2 sites, the Qnr mutants tended to be sus-
ceptible to ciprofloxacin.
To understand the functional consequence of our
mutagenesis experiments, we performed in silico muta-
tions based on the MfpA structure, and subjected them
to MD simulation. The MD simulation of the wild type
MfpA dimer demonstrated that the dimer assembly has
large intermonomer motion in solution. This implied
that the protein has an advantageous structural flexibil-
ity for target recognition or interaction. The L39 D and
L104 D mutations of MfpA perturb the hydrophobic
residues at the i site. As expected, charged residues at
the i site were not tolerated by the hydrophobic core of
the RHQBH. The reorientation of the charged side
chain to the solvent accessible side induced an intercoil
gap in the vicinity of the mutated residues. Similarly, the
L114P MD simulation indicated that the introduction of
aP r or e s i d u et ot h eb-helix structure increased the
intercoil gap in the proximity of the mutated residue.
Some of the intercoil hydrogen bonds were broken and
the structural flexibility around the mutated position
increased remarkably (Fig. 6). Homology modeling of
QnrC gave a similar intercoil disruption at the hexapep-
tide sequence, which showed significant structural flex-
ibility. These structural perturbations to the RHQBH
are very similar to the intercoil disruption caused by cis-
P81 in wild type MfpA. Although the functional impli-
cation of intercoil disruption near P81 is not clear, it
may be a critical structural feature for the Qnr and
MfpA protein family. We note however, that MD simu-
lation at tens of ns may not be able to efficiently sample
all possible larger structural changes in both the muta-
tion systems and homology model structure. Another
limitation of the simulation is that point mutations are
based on the MfpA structure. Therefore, additional bio-
chemical and structural characterizations are needed to
address this issue.
The structure of the MfpA dimer exhibits characteris-
tics similar to B-form DNA in size, shape, and electro-
negative surface potential, and fits comfortably in the
DNA-binding surface of DNA gyrase [11,21], suggesting
a DNA mimicking mechanism of drug resistance. Many
Qnr mutants are defective in fluoroquinolone resistance,
so we propose that the resistance mechanism for Qnr
and MfpA is different from enzymes that have an active
site or catalytic domain. Qnr proteins protect bacteria
from fluroquinolone attack by inhibiting the activity of
DNA gyrase, thus slowing down the growth of bacteria
[22]. Therefore enhanced function of Qnr proteins is
likely to be lethal to the host cell. This may explain why
few Qnr mutants have been found that have elevated
MIC values. Quinolone resistance of the Qnr protein
Figure 4 Structure-based sequence alignment of the six PRP
proteins with known structures showing the sequence
diversity. Conserved residues are highlighted in red.
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Page 7 of 11Figure 5 The structure of QnrC protein (residue 1 to 165) based on homology modeling. (a) Tube representation with all side chains of
residues at position i. The structure adopts a b-helix fold. Leu and Phe at i positions are well aligned at Face 1, 2, 3 and 4. (b) and (c) illustrate
the distribution of type II (in blue) and type IV (in green) b-turns formed by residues at position i
+1, i
+2 and the residue at position i
-2 in the
subsequent pentapeptide in the model structure (b) and in sequence (c). The turn involved in the hexapeptide segment (F54 to C57) is in
orange. The two turns (M44 to C46 and F140 to N142) that switch between type II and type IV frequently during the structure optimization MD
simulation are highlighted in yellow.
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products, and the physiological role of PRPs in prokar-
yotic cells remains elusive [11].
Conclusions
In this study, several Qnr mutants with defective activity
were obtained by random or site-directed mutagenesis,
but none had enhanced function. The conserved PRP
residues at the i and i
-2 sites were of great importance
to Qnr protein function. The introduction of Pro to the
b-helix caused protein dysfunction. The C- and N-ter-
mini, and the G56 region were also crucial to Qnr pro-
tein function. Molecular dynamics simulations and
homology modeling revealed that QnrC adopts a stable
b-helix fold with strong structural similarity to MfpA.
Both QnrC and MfpA showed significant structural
Figure 6 Intercoil distance variations of QnrC along the MD simulation trajectory. The intercoil distance is defined as the distance
between Ca atoms of residue (i) and residue (i+20) in the subsequent coil. (Note that for residues N34 to F54 [shadowed], the distance is
between Ca [i]t oC a [i+21].) The average value (a) and the standard deviation (b) of the distances were calculated for the last 10 ns of the MD
simulation. The points involved in the gap between coil 2 and coil 3 are in red.
Guo et al. BMC Structural Biology 2010, 10:33
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Page 9 of 11flexibility that might be favorable to target recognition
or interaction.
Methods
Construction of random mutation libraries of qnrC and
qnrA1
The qnrC-carrying plasmid pHS10 was isolated from a
clinical strain of P. mirabilis 06-489 from Huashan Hos-
pital, a teaching hospital at F u d a nU n i v e r s i t yi nS h a n g -
hai [6]. The qnrA1 carried by plasmid pMG252 was
donated by Professor G.A. Jacoby [2]. Random muta-
tions were generated in the qnrC and qnrA1 genes using
the Genemorph II Random Mutagenesis Kit (Stratagene,
La Jolla, CA, USA.). Error-prone 904 bp and 921 bp
PCR fragments encompassing the entire transcription
units of qnrC and qnrA1 were amplified with pHS10 or
pMG252 as the templates, and primers qnrCBam/
qnrCSal [6] and qnrA1Sal/qnrA1Eco (Table 1). PCR
products were cloned into pHSG398, containing Chl
r
conferring resistance to chloramphenicol (Takara Bio,
Otsu, Japan), and recombinants transformed into E. coli
TOP10 (Invitrogen) with selection on tryptic soy agar
(TSA, Oxoid, Basingstoke, England) plates containing
chloramphenicol 34 μgm l
-1. The resultant plasmids
were isolated, and inserts were verified by sequencing.
Wild type recombinants containing qnrC and qnrA1
genes were called pHS12 [6] and pMG252-1.
Site-directed mutagenesis of qnrC and qnrA1
To explore the potential function of the N- and C-ter-
mini, and the G56 region of Qnrs, nucleotide deletions
were introduced into qnrC and qnrA1 for multiple
amino acid deletions using a QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). Complemen-
tary primers with the desired mutation were designed,
flanked by unmodified nucleotide sequence using Strata-
gene’s web-based QuikChange Primer Design Program
(http://www.stratagene.com/qcprimerdesign, see Addi-
tional file 1). Mutagenesis used the experimental proto-
col of the manufacturer. For example, primers used for
deletion mutation of residue 11-20 for QnrC were
QnrC-Δ11-20-F (5’- CCCATAAAACGTACGATCAA—
CATCACTTTTCTCACTG -3’)a n dQ n r C - Δ11-20-R
(5’- CAGTGAGAAAAGTGATG—TTGATCGTACGTT
TTATGGG -3’). Dashes indicate deleted nucleotides
that encode amino acids 11-20 of QnrC. For whole-plas-
mid amplificaiotn, 5-50 ng of recombinant plasmid
pHS12 or pMG252-1 was used as template in a Quik-
Change amplification reaction with PfuTurbo DNA
polymerase. PCR products were digested with Dpn I
restriction enzyme at 37°C for 1 hour, then 1 μ-l of the
Dpn I-treated DNA was transferred to E. coli TOP10
competent cells. Transformants were selected with
chloramphenicol, and mutations were verified by DNA
sequencing. Single amino acid substitutions at the i and
i
-2 sites and in other conserved residues of Qnr, and
codons for mutant residues are shown in Table 1.
Susceptibility testing
MICs of ciprofloxacin for random or site-directed
mutants were determined by CLSI agar dilution metho-
dology [23]. Mutants with elevated or decreased MICs
were confirmed by E test (Biodisk AB, Solna, Sweden).
Molecular dynamics simulation
Software package NAMD 2.6 [24] was employed for
MD simulation using CHARMM27 force field. Simula-
tion conditions were maintained at 1.01325 bar by the
Nòse-Hoover Langevin piston method [25] and 300 K
by Langevin dynamics [26]. The MfpA dimer was
selected as the model system for Qnr proteins. Crystal
structures were obtained from PDB bank (PDBID:
2BM7) and solvated with TIP3P water molecules [27].
After 1000 steps of energy minimization, the solvent of
the system was equilibrated for 200 ps with all protein
atoms fixed. Restraints were removed and the system
was gradually heated from 25 K to 300 K. The produc-
tion runs lasted for 10 ns with a time step of 2 fs. Tra-
jectories were saved every 5 ps and data analysis used
VMD 1.8.6 [28].
Homology modeling of QnrC
The SWISS-MODEL protein structure homology-mod-
eling server [29] was used to construct the QnrC struc-
ture. The residues from 1 to 165, which constitute a
tandemly pentapeptide repeat sequence of QnrC, were
used in model building. The crystal structure of the
typical pentapeptide repeat protein Np275/276 (PDBID:
2J8K) was selected as the template. Model structures
were first optimized with 10-ns MD run with all back-
bone atoms fixed. Then restraints were gradually
removed in 5 ns, and the system was further equili-
brated for another 20-ns MD simulation.
Nucleotide sequence accession numbers
The qnrC and qnrA1 mutant sequences have been sub-
mitted to GenBank with accession numbers HM011089
to HM011102 and HM011060 to HM011088.
List of abbreviations
PRP: pentapeptide repeat protein; MIC: minimal inhibi-
tory concentration; RMSD: root-mean-square deviation;
RHQBH: right-handed quadrilateral b-helix; MD: mole-
cular dynamics.
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